NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

痤瘡藥物市場規模調查:痤瘡藥物類型,藥物類別,藥物類型,給藥途徑-2025全球預測-COVID-19的累積影響

Acne Drugs Market Research Report by Acne Type, by Drug Class, by Drug Type, by Route of Administration, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

出版商 360iResearch LLP 商品編碼 990516
出版日期 內容資訊 英文 199 Pages
商品交期: 最快1-2個工作天內
價格
痤瘡藥物市場規模調查:痤瘡藥物類型,藥物類別,藥物類型,給藥途徑-2025全球預測-COVID-19的累積影響 Acne Drugs Market Research Report by Acne Type, by Drug Class, by Drug Type, by Route of Administration, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19
出版日期: 2021年06月01日內容資訊: 英文 199 Pages
簡介

全球痤瘡藥物市場預計將從2020年的5,123.97百萬美元增長到2025年底的7,146.37百萬美元。

市場細分和覆蓋率

這項研究對痤瘡藥物進行分類,預測收入並分析以下每個子市場的趨勢:

通過痤瘡,對痤瘡,痤瘡,囊腫,炎症和術後/傷口的痤瘡藥物市場進行了調查。

按藥物類別,對痤瘡藥物市場進行了調查,涉及抗生素,伴隨藥物,激素藥和類維生素A。

根據藥物類型,對痤瘡藥物市場進行了OTC和處方藥調查。

通過給藥途徑,對痤瘡藥物市場進行了跨注射,口服和局部使用的調查。

按地區,痤瘡藥物市場在美洲,亞太地區,歐洲和中東/非洲進行了調查。

COVID-19的累積影響

預計COVID-19將在預測期內對行業增長產生長期影響,因為這是無與倫比的全球公共衛生突發事件,幾乎影響了每個行業。我們正在進行的研究擴大了研究框架,以確保它包括潛在的COVID-19問題和潛在的未來路徑。該調查提供了對COVID-19的見解,並考慮了消費者行為和需求,購買模式,供應鏈改路,當前市場勢力動態以及政府的主要干預措施的變化。更新後的調查提供了見解,分析,估計和預測,其中考慮了COVID-19對市場的影響。

報告提供了有關以下準則的見解:

1.市場滲透率:主要參與者提供的全面市場信息

2.市場開發:有利可圖的新興市場的詳細信息和市場分析

3.市場多元化:有關新產品發佈,欠發達地區,最新發展和投資的更多信息

4.競爭評估和情報:全面評估主要公司的市場份額,戰略,產品和製造能力

5.產品開發和創新:對未來技術,研發活動和新產品開發的智能見解

報告回答以下問題:

1.全球市場的規模和預測是什麼?

2.在預測期內,構成市場的COVID-19有哪些障礙和影響?

3.在預測期內,您將投資哪些產品,細分市場,應用或領域?

4.市場機會的競爭性戰略窗口是什麼?

5.市場的技術趨勢和監管框架是什麼?

6.哪些模式和戰略舉措被認為適合進入市場?

本報告調查了痤瘡藥物市場,並分析了市場概況,市場增長和抑制因素,痤瘡藥物類型,藥物類別,藥物類型,給藥途徑和區域市場規模,提供了有關趨勢和預測的全面信息, COVID-19的累積影響,競爭條件,主要公司的形象,市場機會等等。

目錄

第1章簡介

  • 調查目的
  • 市場細分和覆蓋範圍
  • 調查對像年度
  • 貨幣和價格
  • 語言
  • 限制
  • 利益相關者

第2章調查方法

  • 調查過程
    • 定義:調查目的
    • 決策:調查設計
    • 準備:測量設備
    • 集合:數據源
    • 分析:數據解釋
    • 公式:數據驗證
    • 已發佈:調查報告
    • 重複:報告更新
  • 進行調查
    • 開始:調查過程
    • 計劃:創建調查計劃
    • 執行:進行調查
    • 驗證:發現和分析
    • 出版物:調查報告
  • 調查結果

第3章執行摘要

  • 簡介
  • 市場前景
  • 按藥物類型劃分的展望
  • 按管理途徑劃分的Outlook
  • 毒品類別的展望
  • 按痤瘡類型劃分的Outlook
  • 區域展望
  • 競爭對手的展望

第4章市場概述

  • 簡介
  • COVID-19的累積效果

第5章市場洞察

  • 市場動態
    • 促進因素
    • 抑製器
    • 市場機會
    • 挑戰
  • 搬運工五力分析
    • 新進入者的威脅
    • 替代威脅
    • 客戶的議價能力
    • 供應商的談判能力
    • 行業競爭

第6章按痤瘡藥物類型劃分的全球痤瘡藥物市場

  • 簡介
  • 喜劇演員
  • 囊腫
  • 炎性的
  • 術後/傷口

第7章按藥物類別劃分的全球痤瘡藥物市場

  • 簡介
  • 抗生素
  • 伴隨藥物
  • 激素製劑
  • 類視黃醇

第8章按藥物類型劃分的全球痤瘡藥物市場

  • 簡介
  • 非處方藥
  • 處方藥

第9章,按管理途徑劃分的全球痤瘡藥物市場

  • 簡介
  • 注射
  • 口服
  • 本地

第10章美洲痤瘡藥品市場

  • 簡介
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太痤瘡藥品市場

  • 簡介
  • 澳大利亞
  • 中國
  • 印度
  • 印度尼西亞
  • 日本
  • 馬來西亞
  • 菲律賓
  • 韓國
  • 泰國

第12章歐洲,中東和非洲的痤瘡藥品市場

  • 簡介
  • 法國
  • 德國
  • 意大利
  • 荷蘭
  • 卡塔爾
  • 俄羅斯
  • 沙特阿拉伯
  • 南非
  • 西班牙
  • 阿拉伯聯合酋長國
  • 英國

第13章競爭情況

  • FPNV定位矩陣
    • 象限
    • 經營策略
    • 產品滿意度
  • 市場排名分析
  • 市場份額分析
  • 競爭性SWOT分析
  • 競爭情景
    • 併購
    • 協議,合作和夥伴關係
    • 推出和增強新產品
    • 投融資
    • 獎項,獎項,擴展

第14章企業可用性概況

  • AbbVie Inc.
  • Almirall, S.A.
  • AndroScience Corporation
  • Anterios Inc
  • Bausch Health Companies Inc.
  • Bayer AG
  • BioPharmX, Inc
  • Cipher Pharmaceuticals Inc.
  • Daiichi Sankyo Company, Ltd
  • F. Hoffmann-La Roche AG
  • Foamix Pharmaceuticals Ltd.
  • Galderma S.A.
  • Guthy-Renker LLC
  • Johnson & Johnson Services, Inc
  • Mayne Pharma Group Limited
  • Medicis Pharmaceutical Corporation
  • Mylan N.V
  • Oculus Innovative Sciences
  • Pfizer Inc.
  • Ranbaxy Laboratories Limited
  • Skinvisible Pharmaceuticals
  • Stiefel Laboratories, Inc
  • Sun Pharmaceutical Industries Limited
  • Teva Pharmaceutical Industries Ltd
  • Valeant Pharmaceutical International Inc

第15章附錄

  • 討論指南
  • 許可證和價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MRR-434CCDA051B6

The Global Acne Drugs Market size was estimated at USD 5,123.97 Million in 2020 and expected to reach USD 5,502.11 Million in 2021, at a Compound Annual Growth Rate (CAGR) 7.71% to reach USD 8,004.64 Million by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Acne Drugs to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Acne Type, the Acne Drugs Market was studied across Comedonal, Cystic, Inflammatory, and Postsurgical/Wound.

Based on Drug Class, the Acne Drugs Market was studied across Antibiotics, Combination Drugs, Hormonal Agents, and Retinoids.

Based on Drug Type, the Acne Drugs Market was studied across OTC Drugs and Prescription Drugs.

Based on Route of Administration, the Acne Drugs Market was studied across Injectable, Oral, and Topical.

Based on Geography, the Acne Drugs Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Acne Drugs Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Acne Drugs Market, including AbbVie Inc., Almirall, S.A., AndroScience Corporation, Anterios Inc, Bausch Health Companies Inc., Bayer AG, BioPharmX, Inc, Cipher Pharmaceuticals Inc., Daiichi Sankyo Company, Ltd, F. Hoffmann-La Roche AG, Foamix Pharmaceuticals Ltd., Galderma S.A., Guthy-Renker LLC, Johnson & Johnson Services, Inc, Mayne Pharma Group Limited, Medicis Pharmaceutical Corporation, Mylan N.V, Oculus Innovative Sciences, Pfizer Inc., Ranbaxy Laboratories Limited, Skinvisible Pharmaceuticals, Stiefel Laboratories, Inc, Sun Pharmaceutical Industries Limited, Teva Pharmaceutical Industries Ltd, and Valeant Pharmaceutical International Inc.

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Acne Drugs Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Acne Drugs Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Acne Drugs Market?
  • 4. What is the competitive strategic window for opportunities in the Global Acne Drugs Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Acne Drugs Market?
  • 6. What is the market share of the leading vendors in the Global Acne Drugs Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Acne Drugs Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. Drug Type Outlook
  • 3.4. Route of Administration Outlook
  • 3.5. Drug Class Outlook
  • 3.6. Acne Type Outlook
  • 3.7. Geography Outlook
  • 3.8. Competitor Outlook

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Extensive occurrence of skin-related diseases in individuals such as acne rosacea
      • 5.1.1.2. Burgeoning awareness among people about the perks of using skin care products
      • 5.1.1.3. Increasing presence on potential online retail platforms coupled with available disposable income
    • 5.1.2. Restraints
      • 5.1.2.1. Availability of numerous alternatives for skin care drugs such as Ayurveda
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising proclivity among consumers for cosmetics made of natural ingredients
      • 5.1.3.2. Emerging demand for combination therapy
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulations and complicated process in the approval of cosmetic drugs
  • 5.2. Cumulative Impact of COVID-19
  • 5.3. Porters Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry

6. Acne Drugs Market, by Acne Type

  • 6.1. Introduction
  • 6.2. Comedonal
  • 6.3. Cystic
  • 6.4. Inflammatory
  • 6.5. Postsurgical/Wound

7. Acne Drugs Market, by Drug Class

  • 7.1. Introduction
  • 7.2. Antibiotics
  • 7.3. Combination Drugs
  • 7.4. Hormonal Agents
  • 7.5. Retinoids

8. Acne Drugs Market, by Drug Type

  • 8.1. Introduction
  • 8.2. OTC Drugs
  • 8.3. Prescription Drugs

9. Acne Drugs Market, by Route of Administration

  • 9.1. Introduction
  • 9.2. Injectable
  • 9.3. Oral
  • 9.4. Topical

10. Americas Acne Drugs Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States
    • 10.6.1. California
    • 10.6.2. Florida
    • 10.6.3. Illinois
    • 10.6.4. New York
    • 10.6.5. Ohio
    • 10.6.6. Pennsylvania
    • 10.6.7. Texas

11. Asia-Pacific Acne Drugs Market

  • 11.1. Introduction
  • 11.2. China
  • 11.3. India
  • 11.4. Indonesia
  • 11.5. Japan
  • 11.6. Malaysia
  • 11.7. Philippines
  • 11.8. South Korea
  • 11.9. Thailand

12. Europe, Middle East & Africa Acne Drugs Market

  • 12.1. Introduction
  • 12.2. France
  • 12.3. Germany
  • 12.4. Italy
  • 12.5. Netherlands
  • 12.6. Qatar
  • 12.7. Russia
  • 12.8. Saudi Arabia
  • 12.9. South Africa
  • 12.10. Spain
  • 12.11. United Arab Emirates
  • 12.12. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
    • 13.1.1. Quadrants
    • 13.1.2. Business Strategy
    • 13.1.3. Product Satisfaction
  • 13.2. Market Ranking Analysis
  • 13.3. Market Share Analysis, By Quadrant
  • 13.4. Market Share Analysis, By Company
  • 13.5. Competitive Scenario
    • 13.5.1. Merger & Acquisition
    • 13.5.2. Agreement, Collaboration, & Partnership
    • 13.5.3. New Product Launch & Enhancement
    • 13.5.4. Investment & Funding
    • 13.5.5. Award, Recognition, & Expansion

14. Company Usability Profiles

  • 14.1. AbbVie Inc.
  • 14.2. Almirall, S.A.
  • 14.3. AndroScience Corporation
  • 14.4. Anterios Inc
  • 14.5. Bausch Health Companies Inc.
  • 14.6. Bayer AG
  • 14.7. BioPharmX, Inc
  • 14.8. Cipher Pharmaceuticals Inc.
  • 14.9. Daiichi Sankyo Company, Ltd
  • 14.10. F. Hoffmann-La Roche AG
  • 14.11. Foamix Pharmaceuticals Ltd.
  • 14.12. Galderma S.A.
  • 14.13. Guthy-Renker LLC
  • 14.14. Johnson & Johnson Services, Inc
  • 14.15. Mayne Pharma Group Limited
  • 14.16. Medicis Pharmaceutical Corporation
  • 14.17. Mylan N.V
  • 14.18. Oculus Innovative Sciences
  • 14.19. Pfizer Inc.
  • 14.20. Ranbaxy Laboratories Limited
  • 14.21. Skinvisible Pharmaceuticals
  • 14.22. Stiefel Laboratories, Inc
  • 14.23. Sun Pharmaceutical Industries Limited
  • 14.24. Teva Pharmaceutical Industries Ltd
  • 14.25. Valeant Pharmaceutical International Inc

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing
  • 15.3. Contact Details

LIST OF FIGURES

  • FIGURE 1. GLOBAL ACNE DRUGS MARKET SIZE, 2020 VS 2026 (USD MILLION)
  • FIGURE 2. GLOBAL ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2020 (USD MILLION)
  • FIGURE 3. GLOBAL ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2020 (USD MILLION)
  • FIGURE 4. GLOBAL ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2020 (USD MILLION)
  • FIGURE 5. GLOBAL ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2020 (USD MILLION)
  • FIGURE 6. GLOBAL ACNE DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
  • FIGURE 7. GLOBAL ACNE DRUGS MARKET: MARKET DYNAMICS
  • FIGURE 8. GLOBAL ACNE DRUGS MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 9. GLOBAL ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2020 VS 2026 (%)
  • FIGURE 10. GLOBAL ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2020 VS 2026 (USD MILLION)
  • FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2026
  • FIGURE 12. GLOBAL ACNE DRUGS MARKET SIZE, BY COMEDONAL, 2018-2026 (USD MILLION)
  • FIGURE 13. GLOBAL ACNE DRUGS MARKET SIZE, BY COMEDONAL, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 14. GLOBAL ACNE DRUGS MARKET SIZE, BY CYSTIC, 2018-2026 (USD MILLION)
  • FIGURE 15. GLOBAL ACNE DRUGS MARKET SIZE, BY CYSTIC, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 16. GLOBAL ACNE DRUGS MARKET SIZE, BY INFLAMMATORY, 2018-2026 (USD MILLION)
  • FIGURE 17. GLOBAL ACNE DRUGS MARKET SIZE, BY INFLAMMATORY, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 18. GLOBAL ACNE DRUGS MARKET SIZE, BY POSTSURGICAL/WOUND, 2018-2026 (USD MILLION)
  • FIGURE 19. GLOBAL ACNE DRUGS MARKET SIZE, BY POSTSURGICAL/WOUND, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 20. GLOBAL ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2020 VS 2026 (%)
  • FIGURE 21. GLOBAL ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2020 VS 2026 (USD MILLION)
  • FIGURE 22. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2026
  • FIGURE 23. GLOBAL ACNE DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2026 (USD MILLION)
  • FIGURE 24. GLOBAL ACNE DRUGS MARKET SIZE, BY ANTIBIOTICS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 25. GLOBAL ACNE DRUGS MARKET SIZE, BY COMBINATION DRUGS, 2018-2026 (USD MILLION)
  • FIGURE 26. GLOBAL ACNE DRUGS MARKET SIZE, BY COMBINATION DRUGS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 27. GLOBAL ACNE DRUGS MARKET SIZE, BY HORMONAL AGENTS, 2018-2026 (USD MILLION)
  • FIGURE 28. GLOBAL ACNE DRUGS MARKET SIZE, BY HORMONAL AGENTS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 29. GLOBAL ACNE DRUGS MARKET SIZE, BY RETINOIDS, 2018-2026 (USD MILLION)
  • FIGURE 30. GLOBAL ACNE DRUGS MARKET SIZE, BY RETINOIDS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 31. GLOBAL ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2020 VS 2026 (%)
  • FIGURE 32. GLOBAL ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2020 VS 2026 (USD MILLION)
  • FIGURE 33. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2026
  • FIGURE 34. GLOBAL ACNE DRUGS MARKET SIZE, BY OTC DRUGS, 2018-2026 (USD MILLION)
  • FIGURE 35. GLOBAL ACNE DRUGS MARKET SIZE, BY OTC DRUGS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 36. GLOBAL ACNE DRUGS MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2026 (USD MILLION)
  • FIGURE 37. GLOBAL ACNE DRUGS MARKET SIZE, BY PRESCRIPTION DRUGS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 38. GLOBAL ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2020 VS 2026 (%)
  • FIGURE 39. GLOBAL ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2020 VS 2026 (USD MILLION)
  • FIGURE 40. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2026
  • FIGURE 41. GLOBAL ACNE DRUGS MARKET SIZE, BY INJECTABLE, 2018-2026 (USD MILLION)
  • FIGURE 42. GLOBAL ACNE DRUGS MARKET SIZE, BY INJECTABLE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 43. GLOBAL ACNE DRUGS MARKET SIZE, BY ORAL, 2018-2026 (USD MILLION)
  • FIGURE 44. GLOBAL ACNE DRUGS MARKET SIZE, BY ORAL, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 45. GLOBAL ACNE DRUGS MARKET SIZE, BY TOPICAL, 2018-2026 (USD MILLION)
  • FIGURE 46. GLOBAL ACNE DRUGS MARKET SIZE, BY TOPICAL, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 47. AMERICAS ACNE DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 48. AMERICAS ACNE DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 49. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS ACNE DRUGS MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 50. ARGENTINA ACNE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 51. BRAZIL ACNE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 52. CANADA ACNE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 53. MEXICO ACNE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 54. UNITED STATES ACNE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 55. CALIFORNIA ACNE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 56. FLORIDA ACNE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 57. ILLINOIS ACNE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 58. NEW YORK ACNE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 59. OHIO ACNE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 60. PENNSYLVANIA ACNE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 61. TEXAS ACNE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 62. ASIA-PACIFIC ACNE DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 63. ASIA-PACIFIC ACNE DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 64. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC ACNE DRUGS MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 65. CHINA ACNE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 66. INDIA ACNE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 67. INDONESIA ACNE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 68. JAPAN ACNE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 69. MALAYSIA ACNE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 70. PHILIPPINES ACNE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 71. SOUTH KOREA ACNE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 72. THAILAND ACNE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 73. EUROPE, MIDDLE EAST & AFRICA ACNE DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 74. EUROPE, MIDDLE EAST & AFRICA ACNE DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 75. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA ACNE DRUGS MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 76. FRANCE ACNE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 77. GERMANY ACNE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 78. ITALY ACNE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 79. NETHERLANDS ACNE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 80. QATAR ACNE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 81. RUSSIA ACNE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 82. SAUDI ARABIA ACNE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 83. SOUTH AFRICA ACNE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 84. SPAIN ACNE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 85. UNITED ARAB EMIRATES ACNE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 86. UNITED KINGDOM ACNE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 87. GLOBAL ACNE DRUGS MARKET: FPNV POSITIONING MATRIX
  • FIGURE 88. GLOBAL ACNE DRUGS MARKET: SHARE, BY QUADRANT, 2020
  • FIGURE 89. GLOBAL ACNE DRUGS MARKET: SHARE, BY COMPANY, 2020
  • FIGURE 90. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL ACNE DRUGS MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL ACNE DRUGS MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 4. GLOBAL ACNE DRUGS MARKET SIZE, BY COMEDONAL, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 5. GLOBAL ACNE DRUGS MARKET SIZE, BY CYSTIC, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 6. GLOBAL ACNE DRUGS MARKET SIZE, BY INFLAMMATORY, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 7. GLOBAL ACNE DRUGS MARKET SIZE, BY POSTSURGICAL/WOUND, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 8. GLOBAL ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 9. GLOBAL ACNE DRUGS MARKET SIZE, BY ANTIBIOTICS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 10. GLOBAL ACNE DRUGS MARKET SIZE, BY COMBINATION DRUGS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 11. GLOBAL ACNE DRUGS MARKET SIZE, BY HORMONAL AGENTS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 12. GLOBAL ACNE DRUGS MARKET SIZE, BY RETINOIDS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 13. GLOBAL ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 14. GLOBAL ACNE DRUGS MARKET SIZE, BY OTC DRUGS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 15. GLOBAL ACNE DRUGS MARKET SIZE, BY PRESCRIPTION DRUGS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 16. GLOBAL ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 17. GLOBAL ACNE DRUGS MARKET SIZE, BY INJECTABLE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 18. GLOBAL ACNE DRUGS MARKET SIZE, BY ORAL, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 19. GLOBAL ACNE DRUGS MARKET SIZE, BY TOPICAL, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 20. AMERICAS ACNE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 21. AMERICAS ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 22. AMERICAS ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 23. AMERICAS ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 24. AMERICAS ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 25. ARGENTINA ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 26. ARGENTINA ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 27. ARGENTINA ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 28. ARGENTINA ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 29. BRAZIL ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 30. BRAZIL ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 31. BRAZIL ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 32. BRAZIL ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 33. CANADA ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 34. CANADA ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 35. CANADA ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 36. CANADA ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 37. MEXICO ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 38. MEXICO ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 39. MEXICO ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 40. MEXICO ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 41. UNITED STATES ACNE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 42. UNITED STATES ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 43. UNITED STATES ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 44. UNITED STATES ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 45. UNITED STATES ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 46. CALIFORNIA ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 47. CALIFORNIA ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 48. CALIFORNIA ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 49. CALIFORNIA ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 50. FLORIDA ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 51. FLORIDA ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 52. FLORIDA ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 53. FLORIDA ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 54. ILLINOIS ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 55. ILLINOIS ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 56. ILLINOIS ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 57. ILLINOIS ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 58. NEW YORK ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 59. NEW YORK ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 60. NEW YORK ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 61. NEW YORK ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 62. OHIO ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 63. OHIO ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 64. OHIO ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 65. OHIO ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 66. PENNSYLVANIA ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 67. PENNSYLVANIA ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 68. PENNSYLVANIA ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 69. PENNSYLVANIA ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 70. TEXAS ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 71. TEXAS ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 72. TEXAS ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 73. TEXAS ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 74. ASIA-PACIFIC ACNE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 75. ASIA-PACIFIC ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 76. ASIA-PACIFIC ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 77. ASIA-PACIFIC ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 78. ASIA-PACIFIC ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 79. CHINA ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 80. CHINA ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 81. CHINA ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 82. CHINA ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 83. INDIA ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 84. INDIA ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 85. INDIA ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 86. INDIA ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 87. INDONESIA ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 88. INDONESIA ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 89. INDONESIA ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 90. INDONESIA ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 91. JAPAN ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 92. JAPAN ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 93. JAPAN ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 94. JAPAN ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 95. MALAYSIA ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 96. MALAYSIA ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 97. MALAYSIA ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 98. MALAYSIA ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 99. PHILIPPINES ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 100. PHILIPPINES ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 101. PHILIPPINES ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 102. PHILIPPINES ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 103. SOUTH KOREA ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 104. SOUTH KOREA ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 105. SOUTH KOREA ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 106. SOUTH KOREA ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 107. THAILAND ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 108. THAILAND ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 109. THAILAND ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 110. THAILAND ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA ACNE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 116. FRANCE ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 117. FRANCE ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 118. FRANCE ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 119. FRANCE ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 120. GERMANY ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 121. GERMANY ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 122. GERMANY ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 123. GERMANY ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 124. ITALY ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 125. ITALY ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 126. ITALY ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 127. ITALY ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 128. NETHERLANDS ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 129. NETHERLANDS ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 130. NETHERLANDS ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 131. NETHERLANDS ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 132. QATAR ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 133. QATAR ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 134. QATAR ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 135. QATAR ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 136. RUSSIA ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 137. RUSSIA ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 138. RUSSIA ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 139. RUSSIA ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 140. SAUDI ARABIA ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 141. SAUDI ARABIA ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 142. SAUDI ARABIA ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 143. SAUDI ARABIA ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 144. SOUTH AFRICA ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 145. SOUTH AFRICA ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 146. SOUTH AFRICA ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 147. SOUTH AFRICA ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 148. SPAIN ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 149. SPAIN ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 150. SPAIN ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 151. SPAIN ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 152. UNITED ARAB EMIRATES ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 153. UNITED ARAB EMIRATES ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 154. UNITED ARAB EMIRATES ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 155. UNITED ARAB EMIRATES ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 156. UNITED KINGDOM ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 157. UNITED KINGDOM ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 158. UNITED KINGDOM ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 159. UNITED KINGDOM ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 160. GLOBAL ACNE DRUGS MARKET: SCORES
  • TABLE 161. GLOBAL ACNE DRUGS MARKET: BUSINESS STRATEGY
  • TABLE 162. GLOBAL ACNE DRUGS MARKET: PRODUCT SATISFACTION
  • TABLE 163. GLOBAL ACNE DRUGS MARKET: RANKING
  • TABLE 164. GLOBAL ACNE DRUGS MARKET: SHARE, BY QUADRANT, 2020
  • TABLE 165. GLOBAL ACNE DRUGS MARKET: SHARE, BY COMPANY, 2020
  • TABLE 166. GLOBAL ACNE DRUGS MARKET: MERGER & ACQUISITION
  • TABLE 167. GLOBAL ACNE DRUGS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 168. GLOBAL ACNE DRUGS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 169. GLOBAL ACNE DRUGS MARKET: INVESTMENT & FUNDING
  • TABLE 170. GLOBAL ACNE DRUGS MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 171. GLOBAL ACNE DRUGS MARKET: LICENSE & PRICING
  • TABLE 172. GLOBAL ACNE DRUGS MARKET: CONTACT DETAILS